Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Difusión de la Información , Neumonía Viral , Investigación Biomédica , COVID-19 , China , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/transmisión , Personal de Salud , Humanos , Relaciones Interprofesionales , Neumonía Viral/epidemiología , Neumonía Viral/prevención & control , Neumonía Viral/transmisión , Salud Pública , SARS-CoV-2 , Ciencia , Revelación de la VerdadAsunto(s)
Enfermedades Transmisibles Emergentes/prevención & control , Enfermedades Transmisibles Emergentes/virología , Brotes de Enfermedades/prevención & control , Pandemias/prevención & control , Virosis/prevención & control , Virosis/virología , Virus/aislamiento & purificación , Animales , Investigación Biomédica/economía , Quirópteros/virología , Enfermedades Transmisibles Emergentes/epidemiología , Interacciones Huésped-Patógeno , Humanos , Proyectos Piloto , Virosis/epidemiología , Virus/genética , Zoonosis/transmisión , Zoonosis/virologíaRESUMEN
Tiffany Bogich and colleagues find that breakdown or absence of public health infrastructure is most often the driver in pandemic outbreaks, whose prevention requires mainstream development funding rather than emergency funding.
Asunto(s)
Creación de Capacidad/métodos , Pandemias/prevención & control , Administración en Salud Pública , Teoría de Sistemas , Creación de Capacidad/economía , Salud Global , Agencias Gubernamentales , Humanos , Agencias Internacionales , Cooperación Internacional , Organizaciones sin Fines de Lucro , Administración en Salud Pública/economíaRESUMEN
Most pandemics--eg, HIV/AIDS, severe acute respiratory syndrome, pandemic influenza--originate in animals, are caused by viruses, and are driven to emerge by ecological, behavioural, or socioeconomic changes. Despite their substantial effects on global public health and growing understanding of the process by which they emerge, no pandemic has been predicted before infecting human beings. We review what is known about the pathogens that emerge, the hosts that they originate in, and the factors that drive their emergence. We discuss challenges to their control and new efforts to predict pandemics, target surveillance to the most crucial interfaces, and identify prevention strategies. New mathematical modelling, diagnostic, communications, and informatics technologies can identify and report hitherto unknown microbes in other species, and thus new risk assessment approaches are needed to identify microbes most likely to cause human disease. We lay out a series of research and surveillance opportunities and goals that could help to overcome these challenges and move the global pandemic strategy from response to pre-emption.
Asunto(s)
Pandemias/prevención & control , Zoonosis/epidemiología , Animales , Patógenos Transmitidos por la Sangre , Enfermedades Transmisibles Emergentes/epidemiología , Enfermedades Transmisibles Emergentes/prevención & control , Monitoreo del Ambiente , Salud Global , Política de Salud , Humanos , Cooperación Internacional , Viaje , Virosis/epidemiología , Virosis/prevención & controlRESUMEN
Global cooperation is essential for coordinated planning and response to public health emergencies, as well as for building sufficient capacity around the world to detect, assess and respond to health events. The United States is committed to, and actively engaged in, supporting disease surveillance capacity building around the world. We recognize that there are many agencies involved in this effort, which can become confusing to partner countries and other public health entities. This paper aims to describe the agencies and offices working directly on global disease surveillance capacity building in order to clarify the United States Government interagency efforts in this space.